Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157-1096, United States
NCT Number: NCT00383279
RATIONALE: Finding out which problems affect employment in survivors of gynecologic cancer may help in planning cancer treatment and improve the quality of life of future cancer survivors.
PURPOSE: This research study is looking at ways to improve employment in patients who have survived cervical cancer, uterine cancer, or ovarian cancer.
Looking for future studies?
Notify Me18 year–120 year
Female
Interventional
Not applicable
Winston-Salem, North Carolina, 27157-1096, United States
OBJECTIVES:
OUTLINE: This is a multicenter, pilot study.
Patients complete a survey, meet with a focus group, and undergo a short interview. Patient-designated participants are also interviewed; these individuals may include a health care provider, a significant other, and/or a work supervisor.
PROJECTED ACCRUAL: A total of 70 patients will be accrued for this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Wake Forest University Health Sciences
Other
Improving Employment Among Gynecologic Cancer Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00381888
Adnexal Diseases, Carcinoma
Minneapolis, Minnesota, United States
View Trial DetailsNCT00287885
Adnexal Diseases, Carcinoma
View Trial DetailsNCT01170299
Adnexal Diseases, Anal Cancer
London, England, United Kingdom
View Trial DetailsNCT01216813
Adenocarcinoma of the Gastroesophageal Junction, Adnexal Diseases
London, England, United Kingdom
View Trial Details